Significant association between tumor mutational burden and immune-related adverse events during immune checkpoint inhibition therapies

Cancer Immunology, Immunotherapy : CII
Csaba KerepesiColin C Anderson

Abstract

More than 2000 immuno-oncology agents are being tested or are in use as a result of the cancer immunotherapy revolution. Manipulation of co-inhibitory receptors has achieved tumor eradication in a minority of patients, but widespread immune-related adverse events (irAEs) compromised tolerance to healthy self-tissues in the majority. We have proposed that a major mechanism of irAEs is similar to a graft-versus-malignancy effect of graft-versus-host disease. To verify our hypothesis, we retrieved post-marketing data of adverse events from the U.S. Food and Drug Administration Adverse Event Reporting System. A significant positive correlation was revealed in 7677 patients between the reporting odds ratio of irAEs during immune checkpoint inhibitor therapy and the corresponding tumor mutational burden across 19 cancer types. These results can be interpreted to mean that the ICI drugs unleashed T cells against "altered-self," self, and tumors resulting in better overall survival.

References

Apr 10, 2009·Pharmacoepidemiology and Drug Safety·A Bate, S J W Evans
Feb 2, 2011·Immunobiology·Govindarajan ThangaveluColin C Anderson
Aug 9, 2011·Immunobiology·Tibor BakacsRalph W Moss
Aug 16, 2013·Nature·Ludmil B AlexandrovMichael R Stratton
Nov 20, 2014·The New England Journal of Medicine·Alexandra SnyderTimothy A Chan
Dec 23, 2014·Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation·Madan H JagasiaMary E D Flowers
Apr 20, 2017·Genome Medicine·Zachary R ChalmersGarrett M Frampton
Oct 19, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaret K CallahanMario Sznol
Feb 15, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie R BrahmerUNKNOWN National Comprehensive Cancer Network
Jan 16, 2019·Nature Genetics·Robert M SamsteinLuc G T Morris
Oct 8, 2019·Scandinavian Journal of Immunology·Tibor BakacsColin C Anderson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.